局部应用TT-10改善受损创面愈合
本研究探讨YAP激活剂TT-10对慢性创面愈合的作用。体外实验显示TT-10促进YAP核转位并增强角质形成细胞增殖与迁移;体内实验表明创周皮内注射TT-10通过激活表皮YAP促进再上皮化,加速正常、糖尿病及缺血创面闭合。
要点
- TT-10促进YAP核转位,增强角质形成细胞增殖与迁移。
- 创周皮内注射TT-10在多种慢性创面模型中加速创面闭合。
- TT-10是增强角质形成细胞功能、促进再上皮化的新型候选药物。
核心结论
- TT-10通过激活YAP促进再上皮化,在慢性创面治疗中具有潜力。
研究设计与样本
- 体外实验采用蛋白质印迹和免疫荧光染色检测YAP活性与亚细胞定位,并通过增殖、划痕及凋亡实验评估角质形成细胞生物学功能。
- 在人类和小鼠组织中检测慢性创面YAP活性受损情况。
- 体内实验通过大体观察、苏木精-伊红染色及测量正常、糖尿病和缺血创面的创面面积与间隙评估TT-10疗效。
主要发现
- TT-10促进YAP核转位,提高YAP活性,进而增加角质形成细胞增殖和迁移。
- 创周皮内注射TT-10通过表皮YAP激活促进再上皮化,加速多种慢性创面模型的创面闭合。
临床怎么用
- 作者认为TT-10可作为增强角质形成细胞功能、促进再上皮化的新型治疗候选药物,为整形外科医生处理慢性创面提供创新思路。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In recent decades, chronic wounds have become an increasingly significant clinical concern because of their increasing morbidity and socioeconomic toll. However, there is currently no product available on the market that specifically targets this intricate process. One clear indicator of delayed wound repair is the inhibition of reepithelialization. Yes-associated protein (YAP), which is a potential focal point for tissue repair and regeneration, has been shown to be prominent in several studies. In this context, the authors have identified the pharmacologic product TT-10, which is a YAP activator, as a potential candidate for the treatment of various forms of chronic wounds. METHODS: The role of TT-10 in regulating YAP activity and subcellular localization was determined by Western blotting and immunofluorescence staining. The effect of TT-10 on the biological functions of keratinocytes was assessed by proliferation, wound healing, and apoptosis assays. The impairment of YAP activity in chronic wounds was measured in human and mouse tissues. The in vivo efficacy of TT-10 was examined by gross examination; hematoxylin and eosin staining; and measuring wound areas and gaps in normal, diabetic, and ischemic wounds. RESULTS: The authors' findings suggest that TT-10 facilitates the nuclear transport of YAP, consequently increasing YAP activity, which in turn increases the proliferation and migration of keratinocytes. Moreover, the authors showed that intracutaneous injection of TT-10 along the wound periphery promoted reepithelialization by means of YAP activation in the epidermis, culminating in accelerated wound closure in several chronic wound healing models. CONCLUSION: The authors' research highlights the potential of TT-10 to treat chronic wounds, which is a persistent challenge in tissue repair. CLINICAL RELEVANCE STATEMENT: The authors' research identifies TT-10, a small molecule YAP activator, as a novel therapeutic candidate that enhances keratinocyte function and promotes reepithelialization, offering plastic surgeons an innovative approach to addressing chronic wound challenges.
引用
- Liu Y, Ho C, Wen D, et al. Topical Application of TT-10 Ameliorates Impaired Wound Healing. Plast Reconstr Surg. 2024. PMID: 38652859. doi:10.1097/PRS.0000000000011492
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。